biomarker

Grant to Investigate Tongue Cancer Biomarkers

Researchers at New York University College of Dentistry’s Bluestone Center for Clinical Research have...

Vigilant Biosciences Launches Clinical Studies of Oral Cancer Assay

Vigilant Biosciences has launched patient enrollment for clinical studies of its OncAlert point-of-care qualitative...

Oral Cancer Test Gets European Conformity (CE) Mark

Vigilant Biosciences has received the European Conformity (CE) mark for its OncAlert Oral Cancer...

HPV Antibody May Indicate Cancer Recurrence Risk

HPV infections cause about 80% of oropharyngeal cancers in the United States, according to...

Biomarkers Tallied for Peri-Implant Disease Potential

Dental implants can be effective in replacing failed or missing teeth, ensuring aesthetics and...

Personal Journey Drives Cancer Innovation

Today’s oral cancer detection products typically rely on revealing abnormalities or detecting HPV. Yet...